Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Limited screen use may support concussion recovery process

9

Jun 2026

Limited screen use may support concussion recovery process

Moderate screen time in the first 3 days after concussion is linked to faster recovery, with an average 141 minutes of daily use speeding up symptom resolution by 35%, finds a study of 80 concussed teens published online in the British Journal of Sports Medicine.

NHS pathology staff face unsafe formaldehyde exposure levels

9

Jun 2026

NHS pathology staff face unsafe formaldehyde exposure levels

Routine exposure to harmful levels of the human tissue preservative formaldehyde are risking the health of thousands of NHS staff working in pathology departments across the UK, due to poor monitoring and control, finds an analysis of Freedom of Information (FOI) requests, published online in the journal Occupational & Environmental Medicine.

Statins may help prevent frailty in older adults

9

Jun 2026

Statins may help prevent frailty in older adults

Researchers at Mass General Brigham have demonstrated that older U.S. veterans who initiated statin therapy were significantly less likely to develop frailty over time, suggesting that the cholesterol-lowering medications may have healthy aging benefits beyond cardiovascular disease prevention. Results are published in the European Heart Journal.

Obesity drug mazdutide reduces weight and waist size in major trial

9

Jun 2026

Obesity drug mazdutide reduces weight and waist size in major trial

Once-weekly 9 mg mazdutide produced clinically meaningful weight loss in Chinese adults with obesity, reducing body weight by 16.65% after 60 weeks versus 1.50% with placebo. The phase 3 GLORY-2 trial also found improvements in waist circumference, systolic blood pressure, and lipid markers, but gastrointestinal adverse events were common.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.